Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mitchell

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
International Journal of Population Data Science|May 6, 2022
The Children's Data Network: Harnessing the scientific potential of linked administrative data to inform children's programs and policiesRegan Foust, Jonathan Hoonhout, Lane Eastman Andrea, et al.
Prenatal Diagnosis|January 7, 2012
Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomyAndrew B Sparks, Eric T Wang, Craig A Struble, et al.
Frontiers in Health Services|June 18, 2026
Lessons learned from a qualitative evaluation of Veterans' experience with the VA tele-PAP program during the COVID pandemicKyu Seo Kim, Ritchie Verma, Alexander Gomez, et al.
JAMA Internal Medicine|October 7, 2024
Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical TrialConstance H Fung, Cathy Alessi, Jennifer L Martin, et al.
Journal of Medicinal Chemistry|December 11, 2013
Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infectionJohn O Link, James G Taylor, Lianhong Xu, et al.
Journal of Medicinal Chemistry|August 17, 2016
Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus InfectionJohn O Link, James G Taylor, Lianhong Xu, et al.
Journal of the National Cancer Institute. Monographs|April 14, 2010
Intraclass correlation estimates for cancer screening outcomes: estimates and applications in the design of group-randomized cancer screening studiesErinn M Hade, David M Murray, Michael L Pennell, et al.
Blood|August 9, 2013
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia ACorien L Eckhardt, Alice S van Velzen, Marjolein Peters, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
International Journal of Population Data Science|May 6, 2022
The Children's Data Network: Harnessing the scientific potential of linked administrative data to inform children's programs and policiesRegan Foust, Jonathan Hoonhout, Lane Eastman Andrea, et al.
Prenatal Diagnosis|January 7, 2012
Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomyAndrew B Sparks, Eric T Wang, Craig A Struble, et al.
Frontiers in Health Services|June 18, 2026
Lessons learned from a qualitative evaluation of Veterans' experience with the VA tele-PAP program during the COVID pandemicKyu Seo Kim, Ritchie Verma, Alexander Gomez, et al.
JAMA Internal Medicine|October 7, 2024
Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical TrialConstance H Fung, Cathy Alessi, Jennifer L Martin, et al.
Journal of Medicinal Chemistry|December 11, 2013
Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infectionJohn O Link, James G Taylor, Lianhong Xu, et al.
Journal of Medicinal Chemistry|August 17, 2016
Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus InfectionJohn O Link, James G Taylor, Lianhong Xu, et al.
Journal of the National Cancer Institute. Monographs|April 14, 2010
Intraclass correlation estimates for cancer screening outcomes: estimates and applications in the design of group-randomized cancer screening studiesErinn M Hade, David M Murray, Michael L Pennell, et al.
Blood|August 9, 2013
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia ACorien L Eckhardt, Alice S van Velzen, Marjolein Peters, et al.
Pageof 13